NCT06398548

Brief Summary

Introduction This study investigates the effects of different intensities of indoor cycling on various health measures. Participants will perform a maximal cycling test to determine their maximal fitness - a strong predictor of overall health - before and after a 6-week training intervention. Blood samples will also be obtained to look at various physiological markers related to extracellular vesicles, inflammation, and metabolism. Who can participate? Healthy young adults who between 18 and 40, are free of immune disease, with a normal body mass index can join this study. They will be divided into three groups:

  • One group will ride a bike at a moderate pace.
  • Another group will ride a bike at a slightly harder pace.
  • The third group won't change their usual daily activities and will continue living as they normally do. What does the study involve? Each exercise session aims to burn a specific amount of calories: 350 for males and 300 for females. Participants cycle 3 times a week for 6 weeks. At the end, we'll repeat the bike test and take another blood sample to see if there have been any changes due to the exercise. Why is this research being done? The researchers want to see how different intensities of exercise impact health and fitness. This may help people make better choices about how much and what type of exercise they should do. What happens after the study? Researchers will analyze the data from the study and see if any differences exist between the protocols. If the participant is interested, we will also provide their blood test results, and the results from their max test.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

May 1, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 3, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

May 8, 2024

Status Verified

May 1, 2024

Enrollment Period

1.7 years

First QC Date

May 1, 2024

Last Update Submit

May 6, 2024

Conditions

Keywords

Lactate ThresholdExercise Intensity DomainVO2peakExtracellular VesiclesMitochondrial Respiration

Outcome Measures

Primary Outcomes (1)

  • Peak oxygen uptake

    The peak oxygen consumption during a maximal staged exercise test

    6 Weeks

Secondary Outcomes (7)

  • Extracellular Vesicle Phenotype

    6 Weeks

  • Extracellular Vesicle Size and Concentration

    6 Weeks

  • Extracellular Vesicle micro RNA Content

    6 Weeks

  • Lactate Threshold

    6 Weeks

  • Peak Power Output

    6 Weeks

  • +2 more secondary outcomes

Study Arms (3)

Control Group

OTHER

This group undergoes the same testing protocols as the intervention groups, but is prescribed no additional exercise.

Other: Control Group

Moderate Intensity Continuous Training

EXPERIMENTAL

In this allocation, participants cycle at 70% the resistance associated with their lactate threshold

Other: Moderate Intensity Continuous Training

Heavy Intensity Continuous Training

EXPERIMENTAL

In this allocation, participants cycle at the resistance associated with their lactate threshold, with an additional 10% of the difference between their LT and maximal achieved watts during the test.

Other: Heavy Intensity Continuous Training

Interventions

Participants continue with their lifestyle as usual, with no modification to lifestyle, or exercise habits.

Control Group

This group cycles at 70% of the resistance associated with their first lactate threshold.

Moderate Intensity Continuous Training

This group cycles at 10% of the difference between the resistance associated with their lactate threshold, and maximal achieved watts, added to the resistance associated with their lactate threshold.

Heavy Intensity Continuous Training

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Are between the ages of 18 and 40 years old.
  • Have a body mass index (BMI) between 18.5 and 30 kg/m\^2.
  • Perform between 60 and 200 minutes of aerobic physical activity per week.
  • Do not have a history of cardiovascular disease or diabetes.

You may not qualify if:

  • Require immunomodulatory medication to treat an auto-immune disease, or rely heavily on over the counter anti-inflammatory medications (e.g., Advil).
  • Have a metabolic condition such as diabetes.
  • Have hypertension (blood pressure \> 160/90 mmHg).
  • Are uncomfortable with blood sampling.
  • Are an elite endurance athlete, or training specifically for an endurance event (\>3 structured aerobic training sessions, or \>150 min of specific aerobic-based/endurance training per week).
  • Adhere to an extreme diet (e.g., ketogenic diet, time restricted feeding).
  • Smoke cigarettes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ART 115

Kelowna, British Columbia, V1V 1V7, Canada

RECRUITING

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Central Study Contacts

Jonathan P Little, PhD

CONTACT

Garett S Jackson, MSc.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
FACTORIAL
Model Details: 3 group randomized controlled trial. 1 control group, 2 exercise groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 1, 2024

First Posted

May 3, 2024

Study Start

May 1, 2023

Primary Completion

December 31, 2024

Study Completion

March 1, 2025

Last Updated

May 8, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

De-identified data may be shared based on reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Data may be available once the manuscript for the study has been published.

Locations